Nicole Jones Sells 2,307 Shares of Cigna Group (NYSE:CI) Stock

Cigna Group (NYSE:CI) insider Nicole Jones sold 2,307 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the sale, the insider owned 32,647 shares of the company’s stock, valued at $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Cigna Group Stock Up 0.2%

CI opened at $284.50 on Thursday. The firm’s 50 day simple moving average is $280.68 and its two-hundred day simple moving average is $284.45. The company has a market capitalization of $74.97 billion, a PE ratio of 12.83, a PEG ratio of 0.98 and a beta of 0.27. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.74.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, topping the consensus estimate of $7.88 by $0.20. The firm had revenue of $72.50 billion for the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The business’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter last year, the company earned $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, equities analysts forecast that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 5th will be issued a $1.56 dividend. The ex-dividend date of this dividend is Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s payout ratio is presently 27.23%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on CI shares. Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Mizuho set a $325.00 price target on shares of Cigna Group in a report on Friday, January 9th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Cigna Group in a research note on Monday, December 29th. Leerink Partners raised their price objective on Cigna Group from $270.00 to $297.00 and gave the company a “market perform” rating in a research report on Friday, February 6th. Finally, UBS Group reaffirmed a “buy” rating and issued a $375.00 target price on shares of Cigna Group in a report on Monday, February 9th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and five have given a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $330.42.

Hedge Funds Weigh In On Cigna Group

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Pure Financial Advisors LLC raised its stake in shares of Cigna Group by 10.1% in the fourth quarter. Pure Financial Advisors LLC now owns 1,719 shares of the health services provider’s stock valued at $473,000 after acquiring an additional 157 shares during the period. SHP Wealth Management bought a new position in Cigna Group during the 4th quarter valued at about $129,000. Employees Provident Fund Board purchased a new stake in Cigna Group in the 4th quarter worth about $20,917,000. Reflection Asset Management bought a new stake in Cigna Group in the fourth quarter worth about $70,000. Finally, CFO Capital Management LLC purchased a new position in shares of Cigna Group during the fourth quarter valued at approximately $243,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

More Cigna Group News

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna’s credit ratings were affirmed by AM Best (Financial Strength Rating A / Long‑Term ICR “a+”), which reduces balance‑sheet and counterparty concerns for investors. AM Best affirms ratings
• Positive Sentiment: Major sell‑side support remains: Piper Sandler kept an Overweight stance and high price target (small trim), and other analysts continue to highlight Cigna’s growth profile after strong earnings. That provides continued analyst backing for the stock. Piper Sandler price target story
• Positive Sentiment: Cigna reaffirmed its 2026 financial outlook while announcing the CEO succession and elected Brian Evanko to the board — the outlook reaffirmation reduces immediate guidance risk. PR Newswire release
• Positive Sentiment: Cigna raised its quarterly dividend (announced recently), which supports income investors and signals management confidence in cash flow. MarketBeat dividend note
• Neutral Sentiment: Management appearances and investor conference activity (TD Cowen) plus regional PR (awards, interviews) provide investor color but are not immediate stock catalysts. TD Cowen presentation notice
• Neutral Sentiment: Profile/interview pieces on outgoing CEO David Cordani and the company’s long-term strategy add context for investors but are informational rather than catalytic. Courant CEO profile
• Negative Sentiment: The CEO succession (David Cordani to retire July 1; President/COO Brian Evanko to succeed) prompted an initial negative market reaction as investors digested leadership change and execution risk, which was the primary near‑term drag on the stock. Seeking Alpha on leadership transition
• Negative Sentiment: Insider selling (recent filings show officers/directors trimming positions) can amplify near‑term downward pressure or signal liquidity needs; monitor whether sales continue. InsiderTrades alert
• Negative Sentiment: Broader healthcare sector weakness this week is a headwind for CI — sector declines can depress even well‑funded insurers in the short term. Yahoo sector update

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.